首页> 外文学位 >Enhanced release of lidocaine from supersaturated solutions of lidocaine in a pressure sensitive adhesive.
【24h】

Enhanced release of lidocaine from supersaturated solutions of lidocaine in a pressure sensitive adhesive.

机译:利多卡因在压敏胶中过饱和溶液中利多卡因的增强释放。

获取原文
获取原文并翻译 | 示例

摘要

Transdermal drug delivery systems consisting of a pressure sensitive adhesive (PSA) supersaturated with drug have been studied with the objective of enhancing drug release. Lidocaine (LC) and Duro-TakRTM87-2287 (PSA) were the model components. In vitro release of drug through a composite membrane consisting of multiple layers of cellulose membrane and a silicone membrane was significantly higher from supersaturated LC/PSA systems compared to systems in which drug had crystallized. Drug loading was an important factor influencing the release of lidocaine from the prototype transdermal delivery systems. The DT2287 PSA hydrated when in contact with water, and the presence of LC accelerated this process. Slow crystallization was also observed during the drug release experiments and was highly dependent on the hydration state of the drug/PSA systems. This suggests that hydration of drug/PSA systems may be an important factor in drug release when water is present. e.g., from the stratum corneum when a transdermal system occludes the skin, and may account for the non-Fickian release of LC from these systems.; The physical stability of the systems was evaluated kinetically and thermodynamically using thermal analysis and then applying theories of nucleation, e.g., the Fisher-Turnbull equation; and phase transformation, e.g., the Avrami equation. From this analysis nucleation rather than the crystal growth process appears to govern the crystallization of LC from the supersaturated LC/PSA systems. Nucleation is a diffusion-controlled process, which is therefore closely dependent on the viscoelastic properties of the PSA medium. Nonetheless some of the thermodynamic features of the crystallization of LC in drug/PSA systems, i.e., Tcrit, were retained from crystalline LC. Crystallization of LC in the PSA systems also had a two-phase temperature dependence with the values of key kinetic parameters, such as the Avrami exponent and the Avrami constant, remaining constant over a low temperature range. Over a higher temperature range, however, the crystallization behavior of LC cannot be explained by the conventional Avrami theory, and a new hypothesis has been proposed suggesting that the nucleation rate increased exponentially with time. To reconcile the apparent differences between the classical theory of nucleation and the proposed hypothesis, a two-step nucleation process is suggested. (Abstract shortened by UMI.)
机译:为了增强药物的释放,已经研究了由一种过饱和的压敏胶(PSA)组成的透皮给药系统。模型组件是利多卡因(LC)和Duro-TakRTM87-2287(PSA)。与药物已经结晶的系统相比,过饱和的LC / PSA系统通过由多层纤维素膜和硅树脂膜组成的复合膜在体外释放的药物明显更高。载药量是影响利多卡因从原型透皮给药系统释放的重要因素。 DT2287 PSA与水接触时会水合,并且LC的存在加速了该过程。在药物释放实验中也观察到缓慢结晶,并且高度依赖于药物/ PSA系统的水合状态。这表明当存在水时,药物/ PSA系统的水合可能是药物释放的重要因素。例如,当透皮系统阻塞皮肤时,来自角质层,并且可以解释这些系统中LC的非费克式释放。使用热分析在动力学和热力学上评估系统的物理稳定性,然后应用成核理论,例如Fisher-Turnbull方程;和相位转换,例如Avrami方程。从该分析中,成核而不是晶体生长过程似乎决定了过饱和LC / PSA系统中LC的结晶。成核是扩散控制的过程,因此紧密依赖于PSA介质的粘弹性质。然而,药物/ PSA系统中LC结晶的一些热力学特征,即Tcrit,保留在结晶LC中。 PSA系统中LC的结晶也具有两相温度依赖性,其关键动力学参数(例如Avrami指数和Avrami常数)的值在低温范围内保持恒定。然而,在较高的温度范围内,传统的Avrami理论无法解释LC的结晶行为,并且提出了新的假设,表明成核速率随时间呈指数增长。为了调和经典成核理论与提出的假设之间的明显差异,提出了两步成核过程。 (摘要由UMI缩短。)

著录项

  • 作者

    Cui, Yong.;

  • 作者单位

    The Ohio State University.;

  • 授予单位 The Ohio State University.;
  • 学科 Health Sciences Pharmacy.
  • 学位 Ph.D.
  • 年度 2003
  • 页码 212 p.
  • 总页数 212
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药剂学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号